Alvotech Eyes Canada Humira Launch As Celltrion Also Bags High-Strength Approval
Celltrion’s Yuflyma And Alvotech/JAMP’s Simlandi Approved By Health Canada
The first biosimilar approval stemming from Alvotech’s collaboration with JAMP Pharma in Canada has arrived, with the firms’ Simlandi (adalimumab) biosimilar version of AbbVie’s higher-strength Humira. Celltrion has also announced an approval from Health Canada.
